Emerging pathogen: Shewanella algae causing burn wound infection - Report of two cases from a tertiary care center
Định dạng: PDF / Số trang: 6
Các file có chung chủ đề
Final results from IMPROVE: A randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients’ preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive,
